This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN shed 1.53% to $2.58 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.42% to 4,130.29 and the Dow Jones Industrial Average DJIA rising 0.97% to 32,845.13. This was the stock's second consecutive day of losses. Ocugen Inc. closed $15.07 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. ADVM fell 5.81% to $1.46, Ocular Therapeutix Inc. OCUL rose 4.19% to $4.48, and Kodiak Sciences Inc. KOD rose 0.61% to $9.95. Trading volume (4.2 M) remained 2.3 million below its 50-day average volume of 6.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 29, 2022.
(END) Dow Jones Newswires
July 29, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.